Scheme

HDFC Pharma and Healthcare Fund

Holds 38 companies worth ₹3,388 Cr in Sept 2026.

  • Fund house

    HDFCThe fund house that runs this scheme.
  • AUM

    ₹3,501 CrHDFC Pharma and Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Up 5.8% on Aug 2026, ₹3,311 Cr.
  • Largest holding

    Divi s Laboratories LimitedDivi s Laboratories Limited is 9.4% of this scheme's NAV.
  • Fund manager

    Nikhil MathurRuns it since 4 Oct 2023, as the fund house dates it. With Bhagyesh Kagalkar (gold & silver), Gopal Agrawal (overseas).

AUM(Dec 2023 – Sept 2026)

AUM at month end each month, and its change on the month before
12 months₹ CrChange
Sept 20263,501+5.8%
Aug 20263,311+12.6%
Jul 20262,940+12.6%
Jun 20262,611+10.7%
May 20262,360+9.3%
Apr 20262,159+9.2%
Mar 20261,977−2.6%
Feb 20262,030+8.1%
Jan 20261,878−5.3%
Dec 20251,984−1.3%
Nov 20252,010+2.2%
Oct 20251,967+3.7%
AUM at month end, Sept 2026
₹3,501 Cr
+78.0% since Oct 2025
Fig. 1.AUM at each month's end, ₹ crore; under All, the quarterly average since 2010. Source: AMFI.

Direct plans(Dec 2023 – Sept 2026)

Direct plans' share of AUM each quarter, and its change on the quarter before
4 quartersShareChange
Sept 202636.69%+2.69 pt
Jun 202634.01%+0.77 pt
Mar 202633.23%−0.69 pt
Dec 202533.93%+0.32 pt
Direct plans' share of AUM, Sept 2026
36.69%
+2.77 pt since Dec 2025
Fig. 2.HDFC Pharma and Healthcare Fund's quarterly average AUM in direct plans, which pay no distributor; changes in points. Source: AMFI.

Returns(9 Oct 2026)

Growth · Direct and Regular plans

To 9 Oct 2026; past a year, a yearly rate. Benchmark: BSE Healthcare TRI. * From NAVs. Source: AMFI. Click a column's header to sort by it.
1 month *
−5.22%−5.31%––−4.51%
3 months *
+1.16%+0.89%––−3.15%
6 months *
+20.32%+19.67%––+4.22%
1 year
+23.21%+21.84%+10.89%+12.32 pt+0.43%
3 years
+29.27%+27.75%+21.02%+8.25 pt+12.61%
Since launch
+29.16%+27.64%+20.87%+8.29 pt+13.17%
Fig. 3.To 9 Oct 2026; past a year, a yearly rate. Benchmark: BSE Healthcare TRI. * From NAVs. Source: AMFI.